ElixSure
This article was originally published in The Tan Sheet
Executive Summary
Alterna extends its children's ElixSure line with spill-resistant formulations of ElixSure Liquid Allergy (diphenhydramine 12.5 mg) in bubble gum flavor and ElixSure EX Liquid Expectorant (guaifenesin 50 mg) in strawberry. The products come in 4 oz. bottles for $5.99 each, and will be available in early fall. The extensions add to the line's current formulations, which include Congestion (pseudoephedrine HCl), Cough (dextromethorphan HBr) and Fever/Pain. Alterna announced its acquisition of the ElixSure line from Taro Consumer in March (1"The Tan Sheet," March 7, 2005, p. 11)...
You may also be interested in...
Taro Readies Branded OTC Exodus With ElixSure, Kerasal Divestiture
Taro's divestiture of its ElixSure cough/cold medicine and Kerasal moisturizer brands in North America to Alterna signals the firm's exit from the branded OTC drug market
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.